Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-011485
Filing Date
2017-02-24
Accepted
2017-02-24 11:10:23
Documents
1
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4488
  Complete submission text file 0001104659-17-011485.txt   6731
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 102 CAMBRIDGE MA 02142 617.252.4343
HealthCare Ventures IX, L.P. (Reporting) CIK: 0001490245 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37990 | Film No.: 17635456

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 THORNDIKE STREET SUITE B1 CAMBRIDGE, MA 02141
Business Address 47 THORNDIKE STREET SUITE B1 CAMBRIDGE, MA 02141 617-252-4343
Healthcare Partners IX, LLC (Reporting) CIK: 0001698828 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37990 | Film No.: 17635455